BioAgilytix scientists will be discussing integrated LC-MS analytical development and GMP testing at the 2026 CASSS Mass Spectrometry Symposium in Rockville.
Published
Signal category
Presence & Recognition
Quote
“At the 2026 CASSS Mass Spectrometry Symposium, our scientists will be discussing how integrated LC-MS analytical development and GMP testing can help sponsors”
— BioAgilytix team
Company
BioAgilytix
Enabling the breakthroughs of tomorrow, today.
- Industry
- Biotechnology Research
- Location
- Durham, US
- Company size
- 929 employees
BioAgilytix is a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development. With laboratory locations in North Carolina’s Research Triangle Park; Cambridge, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development and release testing of therapeutics across a number of industries and disease states. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, GLP, and GCP, as well as GMP quality control testing (i.e., product release testing, stability testing, etc.) BioAgilytix also offers diagnostic testing services at its CLIA-certified, CAP-accredited Boston laboratory. BioAgilytix’s team of highly experienced scientific and QA professionals ensures high-quality science, data integrity and regulatory compliance through all phases of clinical development. BioAgilytix is a trusted partner to many top global pharmaceutical and biotech companies. For more information, visit www.bioagilytix.com.
Founded 2008